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Oxidative stress is well known to play important roles in cartilage degradation and
pathogenesis of OA. The intra-articular injection of hyaluronic acid (IAHA) is accepted as an
effective clinical therapy for OA, but we do not yet fully understand the mechanisms
underlying the effects of HA on OA chondrocytes under oxidative stress. Here, we show for
the first time that IAHA significantly reduces the synovial fluid levels of hydrogen peroxide
(H2O2) and superoxide (O2−) in patients with knee OA. We also demonstrate that HA
suppresses H2O2-induced cell death in human OA chondrocytes. Proteomic approaches
(2-DE combined with mass spectrometry) allowed us to identify 13 protein spots
corresponding to 12 non-redundant proteins as HA-regulated proteins in OA chondrocytes
under oxidative stress. The expression levels of three putative HA-regulated proteins
(TALDO, ANXA1 and EF2) in control, H2O2-, HA- and HA/H2O2-treated OA chondrocytes were
verified by Western blotting and the results indeed support the notion that HA acts inKeywords:
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41J O U R N A L O F P R O T E O M I C S 9 9 ( 2 0 1 4 ) 4 0 – 5 3anti-oxidation, anti-apoptosis, and the promotion of cell survival. Our results collectively
demonstrate the utility of proteomic approaches and provide new insights into the
chondroprotective effects of HA on OA.
Biological significance
In the present study, we show for the first time that IAHA reduces the levels of H2O2 and O2−
in synovial fluids from OA patients. We used primary cultured human OA chondrocytes as a
model, treated cells with H2O2 to partly mimic their physiological conditions under
oxidative stress, and examined the protection effects of HA. The proteomic approach
allowed us to identify candidate proteins regulated by H2O2 and/or HA in OA chondrocytes.
We found that proteins functioning in stress responses, apoptosis and protein synthesis
were consistently regulated by HA in chondrocytes under oxidative stress. These novel
results contribute to our understanding of the molecular mechanisms underlying
HA-mediated chondroprotection.
© 2014 The Authors. Published by Elsevier B.V. All rights reserved.1. Introduction
Osteoarthritis (OA), which is also known as osteoarthroses or
degenerative joint disease, is themost common type of arthritis
worldwide [1–3]. OA is characterized by the erosion of articular
cartilage, which leads to joint-space narrowing, subchondral
sclerosis, subchondral cysts, synovial inflammation, and mar-
ginal osteophyte formation [2,4]. Individuals with OA can suffer
from pain, muscle weakness, decreasing ranges of motion, and
increasing disability. Documented contributors to this patho-
physiology include genetic predisposition, trauma, inflamma-
tion, and metabolic changes [2,5,6].
Hyaluronate or hyaluronic acid (HA) is a high molecular
weight glycosaminoglycan (GAG) composed of repeating
disaccharide units of N-acetylglucosamine and glucuronic
acid [7]. HA is the most abundant GAG in mammalian tissues,
and is present at high concentrations in connective tissues,
such as skin, cartilage, vitreous humor and umbilical cord.
The largest single reservoir of HA is the synovial fluid (SF) of
the diarthrodial joints, where concentrations of 0.5–4 mg/ml
are achieved [1,8] and HA has been shown to mediate the
elastic properties and viscosity of SF. Notably, however, the
concentration and molecular weight of HA are dramatically
reduced in OA joints [9,10]. Intra-articular injection of HA
(IAHA) has been accepted as an effective therapy for OA and
several trials have attempted to evaluate the benefits of IAHA
for knee OA (e.g., improvements in painful knee movements
and general pain relief) [9,11–20]. HA has a very short half-life
(12 to 17 h) once injected into the joint, but its clinical effects
can last six to 12 months [7,15]. Thus, HA appears to provide
its clinical benefits by providing viscous fluid replacement
and triggering multifunctional biological responses.
Reactive oxygen species (ROS), such as hydrogen peroxide
(H2O2), hypochlorite ion (OCl−), hydroxyl radical (UOH) and
superoxide anion (O2−), are derived from oxygen and involve in
both normal intracellular signal transduction and degenerative
cellular processes [21,22]. Elevated production of ROS and/or
depletion of antioxidants has been observed in a variety of
pathological conditions, including inflammatory joint diseases
[22–24]. Specifically, studies have shown that chondrocyte
apoptosis and articular cartilage degradation can be caused by
elevated ROS production, contributing to the aging of cartilageand the pathogenesis of OA [21–23,25–27]. Recently, Miki et al.
demonstrated that HA treatment could attenuate mechanical
stress-enhanced ROS synthesis and reverse proteoglycan syn-
thesis inhibited by mechanical stress in bovine cartilage,
supporting the antioxidant activity of HA [28]. However, we do
not yet fully understand the molecular mechanisms through
which HA offers its chondroprotective effects under oxidative
stress. Here, we report that the levels of H2O2 and O2− in the SF of
OA patients were significantly reduced following IAHA therapy,
and that external HA treatment of human OA chondrocytes
suppressedH2O2-induced cell death in vitro. To gainnew insights
into the HA-regulated proteins that contribute to its
chondroprotective effects under oxidative stress, we used 2-DE
combined withmass spectrometry to identify proteins that were
differentially expressed in OA chondrocytes treated with H2O2
and/or HA. The obtained candidate proteins included subsets
involved in stress, apoptosis/anti-apoptosis and protein synthe-
sis, indicating that HA plays multiple biological roles in OA
chondrocytes under oxidative stress.2. Materials and methods
2.1. Patient population and clinical specimens
This study was approved by the Institutional Review Board for
Research Ethics at the National Taiwan University Hospital
Taipei, Taiwan. Written informed consent was obtained from
each patient prior to enrollment. Cartilage specimens were
collected from 14 OA patients (1 man and 13 women; mean
age, 68 years; range, 28–81 years) who received total knee
replacements. The clinical characteristics of these OA pa-
tients, including gender, age, diagnosis, OA grade, and OA
sites were summarized in Supplementary Table S1. The
cartilage samples were subjected to chondrocyte isolation
immediately after surgery. SF samples were collected from 19
OA patients (7 men and 12 women; mean age, 56 years; range,
40–71 years) who received IAHA therapy (ARTZ® purified
sodium hyaluronate, MW 620–1170 kDa; Seikagaku Corp,
Tokyo, Japan). The SF samples (~2 ml) were aspirated from
patients before and after IAHA treatments. The SF samples
were then stored at −80 °C for further analysis.
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Each cartilage sample was washed with phosphate buffered
saline (PBS), chopped into small pieces (<1 mm3), and treated
with 2 mg/ml type II collagenase (Sigma-Aldrich, St. Louis, MO,
USA) at 37 °C with continuous shaking at 50 rpm for 4 h. The
retrieved chondrocytes were washed three times with PBS and
monolayer cultured in 75-cm2 flasks at an approximate initial
density of 1 × 104 cells/cm2. Chondrocytes were maintained in
DMEM (Invitrogen, Carlsbad, CA, USA) supplemented with
100 units/ml penicillin/streptomycin (Invitrogen), 1%glutamine
and 10% FCS at 37 °C in a humidified atmosphere of 95% air/5%
CO2. When the monolayers were 90% confluent, the cells were
recovered by trypsinization (P0), seeded onto 100-mm or
150-mmculture plates, and subjected toRNA/protein extraction
up to the third passage (P1-P3). The chondrocytic nature of the
cells was confirmed by determination of collagen type I and
type II expressions using reverse transcription polymerase
chain reaction (RT-PCR) and quantitative PCR.
2.3. RNA extraction, RT-PCR and quantitative PCR
Total RNA was extracted using the TRIzol reagent (Invitrogen)
according to the manufacturer's instructions. Total RNA was
measured by absorbance at 260 nm, and subjected to RT-PCR
with a SuperScript III kit (Invitrogen). The utilized primers are
as follows: collagen type II sense, 5′-CAACCAGATTGAGAGA
GCATCC-3′ and antisense, 5′-TGTTTCGTGCAGCCATCCTT-3′;
and GAPDH (endogenous control) sense, 5′-GCCAAAAGGG
TCATCATCTC-3′ and antisense, 5′-GGCCATCCACAGTCTTCT-
3′. The PCR conditions consisted of a single incubation step at
95 °C for 3 min, followed by 25 cycles of 40 s at 95 °C, 30 s at
60 °C and 45 s at 72 °C. The RT-PCR products were analyzed by
electrophoresis in 1.5% agarose gels containing ethidium
bromide. Real-time quantitative PCR (qPCR) was performed
on a 20 μl reaction mixture containing 100 nM forward and
reverse primers, varying amounts of template and 2 × SYBR
Green I reaction mix (KAPA SYBR FAST qPCR Kit, Boston, MA,
USA). The primers used in this study were designed using
Primer Express Software (Applied Biosystems, Foster City, CA,Before After 
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SYBR Green fluorescence intensity was determined using the
Bio-Red MyiQ 5 detection system (Bio-Rad Laboratories Inc.,
Hercules, CA, USA), and the gene level normalized against
that of the18S rRNA as an internal control gene.
2.4. Chondrocytic protein preparation
Chondrocytes were recovered from culture plates by trypsin-
ization, washed twice with PBS in microcentrifuge tubes, and
subjected to centrifugation. The cell pellets were solubilized by
vortexing followed by incubation for 1 h with gentle agitation in
lysis buffer containing 30 mM Tris, 7 M urea, 2 M thiourea, 4%
CHAPS, and 1% dithiothreitol (DTT), pH 8.5. To improve the
performance of 2-DE, the crude extracted proteinswere subjected
to methanol/chloroform precipitation. Briefly, 400 μl methanol
and 100 μl chloroform were added sequentially into 100 μl of
chondrocytic proteins. Themixture was vortexed, supplemented
with 300 μl double-distilled water, and vortexed again. After
centrifugation at 14,000 g for 2 min, the top aqueous layer was
pipetted off and 400 μl of methanol was added to the organic
layer. The protein fraction was obtained by centrifugation at
14,000 g for 3 min, and solubilized in rehydration buffer (8 M
urea, 2 M thiourea, 2% IPG buffer and 130 mM DTT). The
chondrocytic protein solutions prepared from each individual
were quantified using the Bradford protein assay (Bio-Rad
Laboratories Inc).
2.5. 2-DE and image analysis
For the first-dimensional separation of chondrocytic proteins,
300 μg of chondrocytic proteins was subjected to isoelectric
focusing on 18-cm immobilized pH 3–10, non-liner IPG strips
(GE Healthcare, Uppsala, Sweden) using the cup-loading
approach for a total of 80 kVh on an IPGphor II (GE Healthcare)
at 20 °C. For reduction and alkylation, the strips were
equilibrated with equilibration buffer (6 M urea, 30% glycerol,
2% SDS, 0.1 M Tris–HCl, pH 8.0, Bromophenol blue dye)
containing 1% DTT (w/v) for 15 min, and then incubated
with equilibration buffer containing 2.5% iodoacetamide for0
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then transferred to the top of an 8–16% gradient SDS gel, and
second-dimensional electrophoresis was performed at 25 mA
for 5 h. The gels were stained with silver nitrate and the
images were immediately recorded using an ImageScanner
(GE Healthcare). Spot analysis was performed using the
ImageMaster™ 2D Platinum v7.0 software (GE Healthcare).
The procedures include spot detection, spot quantification,
gel matching and statistics analysis. The relative volume of a
spot (%Vol) was applied in spot quantification, because %Vol
is a normalized value that remains relatively independent of
variations due to protein loading and staining by considering
the total volume over all the spots in the image. Sixteen 2-DE
gel images obtained from four OA patients were included inP1
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Fig. 2 –Determine the chondrocytic property of the cells. Chondro
cultured in DMEM. Monolayer was grown to 90% confluence and
passages (P1–P5). (A) Chondrocyte mRNA levels for collagen type
monolayer culture were measured by real-time, quantitative RT-
patient. (B) Ratios of collagen type II to I (COL II/COL I) at the mRN
electrophoresis was used to detect COL II gene expressions at di
amplified in parallel as an internal control. (D) Detections of the
cultured OA chondrocytes (no. 1–14, 14 OA individual). Protein ex
by SDS-PAGE, transferred to PVDF membranes, and probed with
was detected as an internal control. The band detected by anti-C
were seeded on glass coverslips and prepared for immunofluore
endogenous expression of CD44 (red) on the cell surface (phase).this analysis at the same time. The statistical analysis for
multiple comparisons was done by one-way ANOVA. The
protein spots were defined as significantly changed only in
those with a p value less than 0.05.
2.6. In-gel digestion
For protein identification, the silver-nitrate-stained protein
spots were excised and subjected to in-gel tryptic digestion.
Briefly, each gel piece was first destained with freshly prepared
1% potassium ferricyanide and 1.6% sodium thiosulfate
(Sigma-Aldrich), washed with 100 mM NH4HCO3 and 50%
acetonitrile, dehydrated in 100% acetonitrile, and vacuum
dried in a Speed-Vac centrifuge (Savant Instruments, Holbrook,CD44
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cytes were isolated from cartilage samples of OA patients and
cells were harvested (P0) or expanded by subculture for five
I (COL I) and collagen type II (COL II) at different time points in
PCR. The results are shown as means ± SEM from one OA
A levels obtained from (A). (C) RT-PCR followed by agarose gel
fferent time points in monolayer culture (P1–P5). GAPDH was
marker proteins for chondrocyte phenotype in the primary
tracts (30 μg) prepared from OA chondrocytes were separated
the anti-COL II and anti-COMP antibodies, respectively. Actin
OL II antibody indicates the procollagen II. (E) Chondrocytes
scence staining using anti-CD44 antibody to detect the
DNA was stained with Hoechst 33258 (blue).
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digestion with sequencing-grade modified porcine trypsin
(Promega, Madison, WI, USA) overnight at 37 °C. Peptides were
extracted with acetonitrile, and dried in a SpeedVac.
2.7. Reverse phase liquid chromatography–tandem mass
spectrometry
The protein identification was performed by LC–MS/MS as
previously described [29]. Briefly, each peptide mixture was
reconstituted in HPLC buffer A (0.1% formic acid, Sigma, St.
Louis, MO, USA), loaded into a trap column (Zorbax
300SB-C18, 0.3 × 5 mm, Agilent Technologies, Wilmington, DE)
at a flow rate of 0.2 μl/min in HPLC buffer A, and the salts were
washed with buffer A at a flow rate of 20 μl/min for 10 min. The
desalted peptides were then separated on a resolving 10-cm
analytical C18 column (inner diameter, 75 μm) with a 15-μm tip
(New Objective, Woburn, MA). The peptides were eluted by a
linear gradient of 0–10% HPLC buffer B (99.9% ACN containing
0.1% formic acid) for 3 min, 10–30% buffer B for 35 min, 30–35%HA(
BA
*
*
*
*
*
Control 0.9 0.95 1 1.05 1.1
0
20
40
60
80
100
H2O2 concentration (mM)
v
ia
bi
lit
y 
(%
)
0
20
40
60
H2O2 HA/H2O2
C D
Time
HA
Cultu
H2O2
Fig. 3 – HA suppresses H2O2-induced cell death in human OA ch
12-well plates in the presence or absence of the indicated doses
viability. The results are shown as means ± SEM calculated from
using one-way ANOVA, and Tukey HSD was used as a post-test
chondroprotective effects of HA on H2O2-induced cell death. Chon
the presence of H2O2 and/or the indicated doses of HA for 24 h. Th
done as described above; *, p < 0.05. (C) HA could not neutralize
completed DMEM medium (D) with or without HA (6 μg/ml) trea
colorimetric assay kit as described in Materials and methods sec
duplicate well in a 96-well ELISA plate.buffer B for 4 min, 35–50% buffer B for 1 min, 50–95% buffer B for
1 min, and 95% buffer B for 8 min at a flow rate of 0.25 μl/min
across the analytical column.The LC setupwas coupled on line to
a two-dimensional linear ion trap mass spectrometer LTQ-
Orbitrap (Thermo Fisher, San Jose, CA) operated using the
Xcalibur 2.0.7 software (Thermo Fisher, San Jose, CA). The MS
full-scan was performed in the LTQ-Orbitrap with a MS range
from350 Da to 2000 Da and the intact peptidesweredetected at a
resolution of 30,000. Internal calibrationwas performed using the
ion signal of (Si(CH3)2O)6H + at m/z 445.120025 as a lock mass
[30]. The data-dependent procedure that alternated between one
MS scan followed by six MS/MS scans for the six most abundant
precursor ions in theMS survey scanwas applied. Them/z values
selected for MS/MS were dynamically excluded for 180 s. The
electrospray voltage applied was 1.8 kV. Both MS and MS/MS
spectrawere acquired using the onemicroscanwith amaximum
fill-time of 1000 and 100 ms for MS and MS/MS analysis,
respectively. Automatic gain control was used to prevent
over-filling of the ion trap, 5 × 104 ions were accumulated in the
ion trap for generation of MS/MS spectra.0
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ondrocytes. (A) Chondrocytes (5 × 104/well) were cultured in
of H2O2 for 24 h, and MTT assays were used to determine cell
10 OA chondrocytes. Multiple comparisons were performed
for the pairwise comparisons; *, p < 0.05. (B) The
drocytes (5 × 104/well) were plated to 12-well culture plates in
e MTT assay was performed andmultiple comparisons were
H2O2 directly in vitro. H2O2 (1 mM) was added into PBS (C) or
tments. The H2O2 concentration was determined by a
tion. Data are presented as mean values obtained from
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The resulting MS/MS spectra were searched using the Mascot
search engine (version 2.2.06, Matrix Science, London, UK)
against the UniProtKB/Swiss-Prot database (selected for Homo
sapiens, 20,367 entries). The search parameters were set as
follows: carbamidomethylation (C) as the fixed modification,
oxidation (M), N-acetyl (protein) and pyro-Glu/Gln (N-term) as
variable modifications, 10 ppm for MS tolerance, 0.5 Da for
MS/MS tolerance, and 2 formissing cleavage. The validation of
MS/Ms based peptides and protein identifications was per-
formed by the Scaffold proteome software (Version _3_03_02,
Proteome Software Inc., Portland, OR), in which the cutoffs for
peptide thresholds were 95.0% minimum, and protein thresh-
olds were 95.0% minimum and minimum of 2 peptides. Total
spectral count value and sequence coverage for each protein
were used to compare the relative protein levels (abundance)
in peptide mixture derived from one protein spot. The protein
with the most abundance within one peptide mixture was
referred to one protein spot identity. The identified proteins
were further analyzed by using ProteinCenter (Proxeon
Bioinformatics, Odense, Denmark), a proteomics data mining
and management software, in which the identified proteins
were functionally classified based on universal Gene Ontology
(GO) annotation terms, and linked to at least one annotation
term within the GO molecular function and biological process
categories, respectively.Primary cultured OA chondrocytes
HA can rescue the cell death caused by H2O2
Validate targeted proteins by Western blot 
Image analysis
Control     H2O2 HA      HA/H2O2
2-DE
Identify the differentially expressed 
proteins by mass spectrometry
Functional classification of 
differentially expressed proteins
A
Fig. 4 – 2-DE analysis of HA-regulated proteins in OA chondrocyt
workflow used for our proteomic profiling of HA-regulated protein
of chondroprotective effects, 2-DE, mass spectrometric analysis,
blotting. (B) Total proteins (300 μg) from untreated control, H2O2-
subjected to isoelectric focusing (18-cm, pH 3–10, non-liner IPG s
staining.2.9. Cell viability assay
Cell viability was evaluated with 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenytetrazolium bromide (MTT) colorimetric growth
assays, as described previously [31]. Briefly, primary cultured
chondrocytes (5 × 104 cells/well) were plated to 12-well plates
and cultured for the indicated durations with or without H2O2
and/or HA. Following culture, the cells were incubated with
MTT solution (5 mg/ml) (Invitrogen) at 37 °C for 1 h. The
supernatant was aspirated, the cells were treated with DMSO,
and absorbancewasmeasured at 540 nmusing an ELISA reader
(SpectraMax M2; Molecular Devices, Sunnyvale, CA).
2.10. Determination of H2O2 concentration by colorimetric
method
TheconcentrationofH2O2wasdeterminedbyaH2O2 colorimetric
assay kit (Sigma-Aldrich) according to the manufacturer's
instructions.
2.11. Immunofluorescence microscopy
Chondrocytes were grown on coverslips within 12-well plates,
fixed with 4% paraformaldehyde, and subjected to indirect
immunofluorescence staining, as described previously [32]. The
cells were blocked with 0.2% bovine serum albumin and 0.1%
saponin in PBS, followed by incubation with an anti-CD44B
es under oxidative stress. (A) Schematic diagrams show the
s under oxidative stress. The processes include examination
functional classification, and protein validation by Western
treated, HA-treated and HA/H2O2-treated chondrocytes were
trips) followed by SDS-PAGE (8–16% gradient gel), and silver
46 J O U R N A L O F P R O T E O M I C S 9 9 ( 2 0 1 4 ) 4 0 – 5 3antibody (193-020; Ancell, Bayport, MN, USA). After threewashes
with PBS, the cells were exposed to an Alexa 594-conjugated
anti-mouse IgG secondary antibody (Molecular Probes, Eugene,
OR) and Hoechst 33258 dye (Invitrogen) for visualization ofFig. 5 – Functional classification of 12 identified proteins regulated
images obtained from H2O2- and HA/H2O2-treated cells yielded 13
are shown. (B) Functional classification of the differentially expres
software. Proteins were linked to at least one universal GO annota
process categories (C).nuclei. Finally, the cells were mounted in 90% glycerol in PBS
containing 1 mg/ml of ρ-phenylenediamine and observed under
a Zeiss Axio Imager Z1 microscope (Carl Zeiss, Gottingen,
Germany).by HA under oxidative stress. (A) Comparison of the 2-DE
differently expressed protein spots (p < 0.05, one-way ANOVA)
sed proteins shown in (A) was analyzed by ProteinCenter
tion termwithin the GO molecular function (B), and biological
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luminol-amplified chemiluminescence
To evaluate the oxidative status of the SF of OA patients, we
measured H2O2 and O2− using the previously described modified
lucigenin- and luminol-amplified chemiluminescence method
[33]. Briefly, freshly aspirated SF samples were immediately
wrapped in aluminum foil and placed on ice, and analyses were
usually done within 4 h. Chemiluminescence measurements
were performed in the completely dark chamber of a Chemilu-
minescence Analyzing System (CLA-SP2, Tohoku Electronic Ind.
Co., Sendai, Japan). After a 100-s determinationof the background
level, 1.0 ml of 0.1 mM lucigenin in PBS (pH 7.4) or 1.0 ml of mM
luminol was injected into the sample, and chemiluminescence
was continuously monitored for 600 s. The area under the curve
was integrated, the backgroundwas subtracted, and the obtained
value represented the total amount of chemiluminescence. The
assay was performed in duplicate for each sample. The results
were expressed as chemiluminescence counts/10 s, and are
given as the mean ± standard error of the mean (SEM).
2.13. Western blotting
Total protein extracts of OA chondrocytes were subjected to
SDS-PAGE and Western blot analysis using primary antibodies
against COL II (MAB1330; Millipore, Billerica, MA, USA), COMP
(ab128893; Abcam plc, Cambridge, England), TALDO (sc-51440;
Santa Cruz Biotechnology, Santa Cruz, CA, USA), ANXA1
(sc-1923; Santa Cruz) and EF2 (A3806; R&DSystems,Minneapolis,
MN, USA). Bound IgG antibodies were detected with horseradish
peroxidase-labeled secondary antibodies (GE Healthcare), visu-
alized using chemiluminescent substrate (PerkinElmer, Inc.,
Waltham, MA, USA), and then exposed to X-ray film. The
resulting images were acquired by Personal Densitometer SI
(Molecular Dynamics), and quantified by ImageQuant tool 3.0
software (GE Healthcare).
2.14. Statistical analysis
The statistical package, GraphPad Prism 5 (GraphPad Software
Inc., San Diego, CA, USA), was used for all analyses. All
continuous variables were expressed as means ± SEM. Multiple
comparisons were performed with one-way ANOVA. The Tukey
honestly significant difference (Tukey HSD) test was used as a
post-test for pairwise comparisons after one-way ANOVA. A p
value of 0.05 or less was considered significant.3. Results and discussions
3.1. IAHA reduces ROS levels in the SF of OA patients
Although the involvement of ROS in cartilage degradation has
beenwell documented, the specific effects of HAunder oxidative
stress conditions and their underlying molecular mechanisms
are not yet fully understood. To examine whether the
chondroprotective effects of HA could involve the suppression
of ROS, which play important roles in cartilage degradation and
chondrocyte apoptosis [21–23,25–27], we determined the levels
of H2O2 and O2− in SF from OA patients who received IAHA. Asshown in Fig. 1, the levels of H2O2 and O2− in the SF samples were
significantly lower following IAHA (3.8-fold and 4.6-fold, respec-
tively; p = 0.0167 and p = 0.0338, respectively; n = 19), compared
to the before-treatment levels. This result agreed with the
previous report that IAHA may reduce ROS, such as nitric oxide
level in SF [34–36]. Together, these results support the notion
that HA has antioxidant activity.
3.2. HA suppresses H2O2-induced cell death in human OA
chondrocyte through intracellular signaling pathway
As the beneficial effects of IAHA (once a week for 5 weeks) in
clinical practice may last six to 12 months [7,15] and we found
that the levels of H2O2 and O2− in SF were significantly reduced
after OApatients received IAHA therapy, we speculated that HA
may modulate ROS in at least two possible ways: 1) by binding
to surface receptors on chondrocytes and initiating signal
transductions that modulate the intracellular oxidative/
anti-oxidative status (a longer-term effect); and/or 2) by acting
as a ROS scavenger to directly reduce ROS levels in SF (an
immediate effect).
To examine whether HA reduces H2O2 and exerts its
chondroprotective effects through HA-receptor mediated sig-
naling, we used primary cultured chondrocytes from OA
patients as a model for our experiments. Since collagen type II
(COL II) is a typicalmarker of differentiated chondrocytes, while
collagen type I (COL I) expression increases during dedifferen-
tiation, the ratio of mRNA levels of collagen type II to I (COL II/
COL I) has been used as chondrocyte differentiation index [37].
To monitor the differentiated/de-differentiated status of pri-
mary cultured chondrocytes used in this study, we determined
the mRNA levels of COL I and COL II in chondrocytes by real
time, quantitative RT-PCR and calculated the COL II/COL I ratio
in chondrocytes. Fig. 2A showed that monolayer culture
induced a decrease in COL II and an increase in COL I. The COL
II/COL I ratio declined steadily, in which 200-fold and 2000-fold
decreases at first and secondary passage were observed
compared to that determined in the beginning of the culture,
respectively (Fig. 2B). These results were consistent with the
previous reports that chondrocyte is dedifferentiated during
monolayer culture [38]. To confirm the chondrocytic property of
the primary cultured cells used in this study, we used agarose
gel containing ethidiumbromide to detect the gene expressions
of COL II at different time points in monolayer culture (Fig. 2C).
Accordingly, we used the first three passages (P1-P3) that
showed distinct expressions of COL II for further experiments.
We also detected two marker proteins of the chondrocyte
phenotype, COL II and cartilage oligomeric matrix protein
(COMP), by Western blotting. Fig. 2D showed that both of
COL II and COMP proteins were expressed and detected in our
cultured OA chondrocytes. Next, we examined the expression of
CD44, the cell surface receptor for HA binding, on the cultured
chondrocytes by immunofluorescence staining with a specific
anti-CD44 antibody. As shown in Fig. 2E, CD44 was expressed on
the cell surfaces of chondrocytes. We then treated these
chondrocytes with various doses of H2O2 for 24 h, and used
MTT assays to determine the IC50 of H2O2 in these cells. Our
chondrocytes proved to be ROS-sensitive, as 0.9 mM and 1.1 mM
H202 decreased cell viability to 70%and10%, respectively (Fig. 3A).
To examine the chondroprotective effects ofHAonH2O2-induced
Table 1 – Spot quantification and protein identification of differentially expressed proteins regulated by HA under oxidative
stress.
Spot quantificationa
Spot
no.
Spot
match
IDc
Control
(%Vol) d
H2O2
(%Vol) d
HA
(%Vol) d
HA/H2O2
(%Vol) d
Mean
squared
deviation
Coef.
variation
Anova
p value
Ratio e
1 5 0.059 0.017 0.060 0.048 0.021 0.645 0.04216 2.75
2 87 0.024 0.033 0.022 0.021 0.009 0.325 0.04677 0.62
3 93 0.034 0.015 0.044 0.030 0.010 0.448 0.04476 1.95
4 207 0.048 0.109 0.062 0.051 0.041 0.510 0.04740 0.47
5 216 0.059 0.080 0.045 0.028 0.031 0.576 0.00788 0.34
6 313 0.187 0.068 0.147 0.245 0.123 0.783 0.04363 3.59
7 318 0.042 0.083 0.045 0.037 0.026 0.438 0.00483 0.45
8 378 0.107 0.156 0.078 0.071 0.059 0.515 0.04285 0.46
9 404 0.247 0.140 0.216 0.237 0.066 0.352 0.03735 1.70
10 477 0.251 0.120 0.218 0.229 0.076 0.437 0.04896 1.90
11 547 0.029 0.024 0.016 0.098 0.052 0.845 0.04595 4.06
12 614 0.017 0.054 0.022 0.024 0.022 0.550 0.04866 0.44
13 627 0.056 0.026 0.061 0.059 0.023 0.543 0.04726 2.26
a Spot detection and quantification are performed by ImageMaster™ 2D Platinum 7.0 software.
b TheMS/MS spectra are searched usingMascot search engine against the UniProtKB/Swiss-Prot database. The validation ofMS/MS based peptides
and protein identifications are performed by the Scaffold proteome software.
c Protein spot number according to Fig. 5A.
d %Vol, the relative volume of a spot is calculated using the formula:
%Vol ¼ VolXn
S¼1
VolS  100
where VolS is the volume of spot S in a gel containing n spots.
e Average volume ratio, HA/H2O2 co-treatment to H2O2 single treatment.
f Theoretical molecular weight (Mr) and pI according to Mascot search result using UniProtKB/Swiss-Prot database.
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them with various doses of HA with or without 1 mM H2O2 for
24 h, and performed MTT assays. As shown in Fig. 3B, cell
viabilitywasunchangedamong chondrocytes singly treatedwith
HA (1.5–24 μg/ml), but HA can rescue the cell death caused by
H2O2. This rescuewas significant for low doses of HA (3–6 μg/ml),
and was not enhanced by higher doses of HA (12–24 μg/ml).
Regardless of mechanism, we propose that HA may have a
bell-shaped effect on the suppression of H2O2-induced cell death
in OA chondrocyte. It means that the chondroprotective effect of
HA under oxidative condition would be in a concentration
dependent manner.
To rule out the possibility that HA can directly reduce
oxidative stress, we determined the H2O2 concentration in a
cell-free system, in which H2O2 (1 mM) was added into PBS with
or without HA treatments (6 μg/ml). Fig. 3C showed that HA
indeed did not reduce the level of H2O2 (50.35 vs. 49.60 μg/ml) in
vitro.Whenwe addedH2O2 into complete culturemedia (DMEM)
with or without HA, the H2O2 level decreased to 60% of its initial
level in the controlmediumat the starting timepoint, suggesting
that components of themediumacted as direct antioxidant/ROS
scavengers (Fig. 3D). The H2O2 levels in the complete culture
medium decreased to 18.7% and 2.5% of the initial level after 2
and 24 hof incubation, respectively. This result reflects the short
half-life of H2O2 in vitro. Notably, the addition of HA did not
further alter the levels of H2O2 in this cell-free system (Fig. 3D).
Thus, our results strongly suggest that HA does not neutralizeH2O2 directly in our in vitro system and support our hypothesis
that HA reduces ROS and exerts its chondroprotective effects
through intracellular signaling pathway.
3.3. Identifying HA-regulated proteins responsible for the
chondroprotective effects of HA under oxidative stress
As we found that HA treatment has chondroprotective effect
under oxidative stress conditions, we attempted to understand
the potential mechanisms responsible for this effect using
proteomic approaches. A schematic diagram of the experimen-
tal workflow is shown in Fig. 4A. Briefly, chondrocytes obtained
from four OA patients were cultured to 90% confluence in
150-mm dishes and treated with H2O2 and/or HA. After 24 h,
cells were lysed and subjected to 2-DE analysis, and the
ImageMaster™ 2D Platinum v7.0 software was used to perform
between-gel comparative image analyses. The differentially
expressed protein spots were subjected to in-gel digestion and
identified by mass spectrometry. To determine the biological
functions of the identified proteins, ProteinCenter software
based on universal GO annotation terms was used. Proteins of
interest were selected and verified by Western blot analysis.
Following the experimental workflow, approximate 720 protein
spots (range, 645–797) were detected in the silver-stained 2-DE
gels (Fig. 4B). The detected spot numbers of each gel obtained
from four OA patients are listed in Supplementary Table S3. The
statistical analysis of spot quantification revealed that 13 and 5
Table 1 – Spot quantification and protein identification of differentially expressed proteins regulated by HA under oxidative
stress.
Protein identificationb
Protein
accession
numbers
Protein name Mr
(Da) f
pI f Protein
identification
probability
Mass
score
Number of
unique
peptides
Number
of total
spectra
Percentage
sequence
coverage
CH10_HUMAN 10 kDa heat shock protein, mitochondrial 10,932 8.9 100.00% 2030 19 65 99.00%
RAN_HUMAN GTP-binding nuclear protein Ran 24,423 7.0 100.00% 824 11 40 37.00%
RAB14_HUMAN Ras-related protein Rab-14 23,898 8.9 100.00% 509 8 18 40.90%
TALDO_HUMAN Transaldolase 37,542 6.4 100.00% 2690 23 106 52.20%
TALDO_HUMAN Transaldolase 37,542 6.4 100.00% 1563 20 56 46.60%
FSCN1_HUMAN Fascin 54,530 6.8 100.00% 1848 21 72 41.00%
SBP1_HUMAN Selenium-binding protein 1 52,392 5.9 100.00% 2443 26 78 54.20%
2AAA_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa
regulatory subunit A alpha isoform
65,310 5.0 100.00% 3645 33 115 57.60%
EF2_HUMAN Elongation factor 2 95,340 6.4 100.00% 3747 42 124 44.50%
RLA0_HUMAN 60S acidic ribosomal protein P0 34,274 5.7 100.00% 2218 19 85 59.30%
HNRPK_HUMAN Heterogeneous nuclear ribonucleoprotein K 50,979 5.4 100.00% 2020 22 61 48.80%
ANXA1_HUMAN Annexin A1 38,716 6.6 100.00% 1150 19 40 52.00%
TPIS_HUMAN Triosephosphate isomerase 26,669 6.5 100.00% 3127 20 90 78.70%
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ANOVA), in H2O2- and HA-treated chondrocytes compared to
untreated controls, respectively. This limited overlap of differ-
ential protein profiles among four OA patients suggests that the
H2O2 and/or HA may have heterogeneous effects on OA
chondrocytes. However, we could not rule out the possibility
that inherent gel-to-gel and staining variability in 2-DE contrib-
ute to this discrepancy. These spots were excised from the gels,
subjected to tryptic digestion, and identified by LC–MS/MS.
Details of spot quantification and protein identification for
these differentially expressed proteins regulated by H2O2 or HA
are summarized in Supplementary Table S4 and S5. Next,
comparison of the 2-DE images obtained from H2O2- and HA/
H2O2-treated cells yielded 13 differently expressed protein spots
(p < 0.05, one-way ANOVA), including 7 up-regulated and 6
down-regulated protein spots (Fig. 5A). The relative volume
values of these 13 differentially expressed protein spots on the
2-DE gels obtained from each OA patient were shown in
Supplementary Table S6. These spots were excised from the
gels, subjected to tryptic digestion, and identified by LC–MS/MS.
Table 1 showed the details of the spot quantification (spotmated
ID, %Vol, mean squared deviation, coefficient variation, p value,
and ratio) and protein identification (protein accession number,
protein name, molecular weight (Mr), isoelectric point (pI),
identification probability, mass score, number of unique pep-
tides, number of total spectra, and percentage of sequence
coverage), for each differently expressed protein spot.To our knowledge, the most well-documented chondrocyte
proteomes in the literature are those reported by research teams
led by Blanco, Deforce, and Elewaut, who established useful
protein datasets for normal, pathological (OA, inflammation-,
stress- and hypoxia-induced) and pharmacologically treated
chondrocytes [27,39–47]. Our present data largely overlapped
with the previous 10 proteome datasets. To assess the potential
biological functions of the proteins found to be regulated by HA
in OA chondrocytes under oxidative stress, ProteinCenter
software based on universal GO annotation terms was used.
These proteins were linked to at least one annotation term
within the GO molecular function and biological process
categories, respectively. Themost commonmolecular functions
were determined as protein binding (30%), catalytic activity
(20%), nucleotide binding (13.33%) and RNA-binding (13.33%)
(Fig. 5B). The major biological process categories included
metabolic processes (17.54%), cell organization and biogenesis
(12.28%), regulation of biological processes (10.53%), response to
stimulus (10.53%) and transport (10.53%) (Fig. 5C).
3.4. Western blot-based validation of HA-regulated proteins in
OA chondrocytes
To search the promising candidates regulated by HA, we
validated the changes in three proteins that were differen-
tially expressed with high reproducibility in all four OA
patients: transaldolase (TALDO), annexin A1 (ANXA1) and
50 J O U R N A L O F P R O T E O M I C S 9 9 ( 2 0 1 4 ) 4 0 – 5 3elongation factor 2 (EF2), which are involved in stress
responses, apoptosis/anti-apoptosis and protein synthesis,
respectively.C
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Jurkat T cells was shown to increase glucose 6-phosphate
dehydrogenase and 6-phosphogluconate dehydrogenase activ-
ity, increase NADPH synthesis and glutathione levels, and
decrease the levels of reactive oxygen intermediates [49].
TALDO also affects cell survival by regulating caspase 3 activity
and the exposure of phosphatidylserine [49,50]. TALDO thus
plays role in the recycling of glucose 6-phosphate via the PPP,
reduction–oxidation reactions, and cell apoptosis [48,51].
Here, we found that two protein spots corresponding to
TALDO were identified as a HA-regulated protein under
oxidative stress (Fig. 6A and Table 1). Western blotting
showed that the expressions of TALDOwere up-regulated in
H2O2 treated OA chondrocytes with an average of 1.72-fold
compared to control cells, but this effect was significantly
suppressed by HA/H2O2 co-treatment (Fig. 6B and C). These
results were similar to that obtained from 2-DE analysis
(Table 1, spot no. 4 and 5), suggesting that HA triggers the
anti-oxidative and anti-apoptotic effects of TALDO as part
of its chondroprotective effects.
ANXA1, a member of the annexin protein family, is a
calcium/phospholipid-binding protein that involves in exocy-
tosis, inflammatory signaling, cell proliferation and apoptosis
[52–55]. Overexpression of ANXA1 suppresses cell proliferation,
while its knockdown reduced cell apoptosis, supporting its role
in cell survival [53,56,57]. Here, the average expression levels of
ANXA1 in H2O2-treated OA chondrocytes were 1.52-fold higher
than those in control cells (Fig. 6B and C). In contrast, cells
co-treated with HA and H2O2 showed that ANXA1 expression
levelswere similar to those in control cells (Fig. 6B and C). Thus,
HA abolished the H2O2-induced up-regulation of ANXA1 poten-
tially explaining the positive effects of HA on cell survival under
oxidative stress.
EF2, one of the critical enzymes governing the elongation of
nascent proteins, is a member of the GTP-binding elongation
factor family that is involved in protein biosynthesis. Together
with its kinase (EF2 kinase), EF2 tightly controls the GTP-
dependent ribosomal translocation step during the elongation
phase of protein synthesis, and modulates the cell cycle [58]. A
recent study demonstrated that EF2 overexpression suppresses
the caspase 3 and 9-mediated apoptosis, and cytochrome C
release induced by HIV-1 viral protein R, further supporting the
notion that EF2 processes anti-apoptotic activity [59]. The
expression levels of EF2 in HA/H2O2-treated cells were a little
bit increased (1.25-fold), compared to that in H2O2-treated cells
(Fig. 6B and C). This result was inconstant with that obtained
from our 2-DE analysis, in which EF2 was down-regulated by
H2O2 and this regulation was significantly rescued by HA
treatment (Table 1, spot no. 9). However, three protein spots
corresponding to EF2 were further identified by LC–MS/MS
(Fig. 6A). These multiple spots might reflect post-translational
modification (PTM) of EF2, such as phosphorylation, ADP-
ribosylation and oxidation. Unfortunately, the antibody used
in our Western blotting (Fig. 6B) could not distinguish these
three EF2 isoforms that might result in the discrepancy of our
results obtained from 2-DE and Western blotting. Because
protein synthesis may be inhibited by oxidative stress via EF2
[60,61], future studies are warranted to identify the PTM status
of EF2 under oxidative stress and following HA treatment. This
could help us understand the roles of PTM in the action of HAand provide further insights into the chondroprotective effects
of HA.4. Conclusions
We herein demonstrate that IAHA suppresses ROS levels (i.e.,
H2O2 and O2−) in the SF of OA patients, and provide the first
overview of HA-induced proteomic changes in human OA
chondrocytes under oxidative stress. Our results further indicate
the HA-mediated chondroprotection through multiple intracel-
lular regulations. The HA-mediated differential expressions of
three proteins (TALDO, ANXA1 and EF2) were verified by
Western blotting and the results support the notion that HA
acts via multiple biological processes, including anti-oxidation,
anti-apoptosis, promotion of protein synthesis, and cell survival.
This study has several limitations, including de-differentiation
of chondrocytes during monolayer culture, the heterogeneity of
clinical characteristics of OA patients, the different passages of
chondrocytes used in discovery/validation phases, and the
inherent gel-to-gel variability in 2-DE analysis. Although future
work is warranted to study the molecular regulations and
interaction networks regulated by HA, the 12 proteins found to
be differently expressed in HA/H2O2-treated cells versus H2O2--
treated cells should be considered viable candidates for confer-
ring the chondroprotective effects of HA.Acknowledgments
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